Skip to content

Tracking of Upper Limb Sensory and Motor Recovery in Asian Stroke Survivors

Deep Phenotyping of Upper Limb Sensori-motor Recovery in Asian Stroke Survivors: Concept, Development and Implementation of a Rehabilomics-driven Technology-assisted Data Platform

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05322837
Enrollment
400
Registered
2022-04-12
Start date
2023-04-26
Completion date
2026-01-31
Last updated
2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

As Singapore's population is aging rapidly, the incidence rate of stroke has been increasing in the past years. Rehabilitation is essential for the resumption of daily activities, and with the appropriate care, it is possible for stroke-survivors to regain most of their functions. Hence, this study aims to better understand upper limb recovery covering different stages post-stroke in a representative cohort of Asian adults

Detailed description

Stroke is a leading contributor to disability in Singapore, partially driven by a reduced ability to use the upper limb in their daily lives. Reduced upper limb use commonly results from a variety of impairments such as motor, sensory and cognitive impairments. The aim of this longitudinal and observational study is to gather a rich multi-modal database on the time-course of upper limb recovery in a representative cohort after stroke and characterise the relationship between upper limb recovery, common post-stroke impairments and quality of life.

Interventions

Assessments and questionnaires related to upper limb function and quality of life will be used

Sponsors

Rehabilitation Research Institute of Singapore (RRIS)
CollaboratorUNKNOWN
Singapore-ETH Centre (SEC)
CollaboratorUNKNOWN
Tan Tock Seng Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Stroke confirmed by neurologists, neurosurgeons and brain imaging (CT, CT angiogram, MRI, MR angiogram) 2. First ever confirmed stroke 3. Asian ethnicity 4. Age 21-90 years 5. Montreal Cognitive Assessment (MOCA) scores 21/30 and above 6. Admission to rehabilitation ward is within 8 weeks of stroke onset

Exclusion criteria

1. Recurrent stroke or transient ischaemic attack (TIA) 2. Upper limb impairment not related to stroke: e.g., subarachnoid haemorrhage, traumatic brain injury or brain tumours 3. Bilateral upper limb impairment. 4. Uncontrolled medical conditions such as hypertension, hypotension, diabetes mellitus, unstable angina, cardiac failure or sepsis will be excluded. 5. Active fractures or arthritis of upper limb joints/bones 6. Visual Analogue Scale (VAS) pain \> 5/10 7. MOCA \< 21/30 8. Severe behavioural disturbance or agitation or epilepsy or untreated depression 9. Life expectancy \< 6 months 10. End organ failures on replacements (renal dialysis or renal replacement therapies) 11. Minimally responsive or unresponsive awareness (vegetative) states 12. Pregnancy or lactation states 13. Admission to rehab ward later than 8 weeks post-stroke 14. (For TMS assessments only) History of epilepsy or seizures, or cranial surgeries, or have metal implants in body or head, or have implanted electronics, or have metallic valve, or skull fracture or brain injury, or head or brain surgeries.

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment (FMA)Inpatient: week 1 of admissionThe FMA-UE is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, in patients with post-stroke hemiplegia.

Countries

Singapore

Contacts

Primary ContactMegan Lau Si En
Megan_SE_Lau@ttsh.com.sg68894580

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026